Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$554M |
| 2 |
Broadcom
AVGO
|
+$378M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$324M |
| 4 |
Warner Bros
WBD
|
+$321M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$454M |
| 2 |
iShares MBS ETF
MBB
|
+$441M |
| 3 |
AT&T
T
|
+$266M |
| 4 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$198M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.98% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 12.8% |
| 4 | Consumer Discretionary | 9.34% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Clear Secure
YOU
$5.57B
| $4.11M | ﹤0.01% |
205,272
+138,113
| +206% | +$3.73M |
|
2277
Hertz
HTZ
$499M
| $4.1M | ﹤0.01% |
258,586
-942
| -0.4% | -$18.6K |
|
|
CSII
2278
DELISTED
Cardiovascular Systems, Inc.
CSII
| $4.09M | ﹤0.01% |
284,849
-7,876
| -3% | -$137K |
|
|
DX
2279
Dynex Capital
DX
$3.15B
| $4.07M | ﹤0.01% |
255,352
-9,150
| -3% | -$145K |
|
|
REVG
2280
DELISTED
REV Group
REVG
| $4.05M | ﹤0.01% |
372,611
+72,056
| +24% | +$853K |
|
2281
Janus International
JBI
$700M
| $4.05M | ﹤0.01% |
448,477
+167,554
| +60% | +$1.63M |
|
2282
TPG
TPG
$7.01B
| $4.04M | ﹤0.01% |
169,061
-5,500
| -3% | -$148K |
|
2283
Byline Bancorp
BY
$1.78B
| $4.04M | ﹤0.01% |
169,731
-2,832
| -2% | -$68.4K |
|
|
AGTI
2284
DELISTED
Agiliti Inc
AGTI
| $4.02M | ﹤0.01% |
196,088
+4,730
| +2% | +$94.4K |
|
2285
Aurora
AUR
$12.6B
| $4.02M | ﹤0.01% |
2,103,973
+200,810
| +11% | +$739K |
|
2286
Winmark
WINA
$1.2B
| $4M | ﹤0.01% |
20,470
-2,326
| -10% | -$477K |
|
2287
TG Therapeutics
TGTX
$7.96B
| $4M | ﹤0.01% |
941,672
-13,751
| -1% | -$85.9K |
|
2288
Yext
YEXT
$547M
| $4M | ﹤0.01% |
837,402
-3,226
| -0.4% | -$17.9K |
|
|
FARO
2289
DELISTED
Faro Technologies
FARO
| $4M | ﹤0.01% |
129,695
-2,735
| -2% | -$100K |
|
2290
Alto Ingredients
ALTO
$369M
| $4M | ﹤0.01% |
1,077,098
+190,950
| +22% | +$998K |
|
|
NGM
2291
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $4M | ﹤0.01% |
311,675
+12,128
| +4% | +$168K |
|
2292
Marcus Corp
MCS
$897M
| $3.98M | ﹤0.01% |
269,742
+30,773
| +13% | +$473K |
|
2293
Marathon Digital Holdings
MARA
$4.32B
| $3.95M | ﹤0.01% |
739,860
+9,801
| +1% | +$131K |
|
2294
Regional Management Corp
RM
$301M
| $3.95M | ﹤0.01% |
105,650
+10,918
| +12% | +$483K |
|
|
PAYA
2295
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $3.95M | ﹤0.01% |
600,721
-12,421
| -2% | -$70K |
|
2296
Hims & Hers Health
HIMS
$6.43B
| $3.95M | ﹤0.01% |
871,024
+254,810
| +41% | +$1.09M |
|
|
NVTA
2297
DELISTED
Invitae Corporation
NVTA
| $3.94M | ﹤0.01% |
1,616,099
+37,445
| +2% | +$166K |
|
2298
Quanterix
QTRX
$164M
| $3.9M | ﹤0.01% |
240,590
-17,128
| -7% | -$352K |
|
2299
DocGo
DCGO
$64.3M
| $3.89M | ﹤0.01% |
545,300
+165,173
| +43% | +$1.2M |
|
|
DHIL
2300
DELISTED
Diamond Hill
DHIL
| $3.87M | ﹤0.01% |
22,298
-547
| -2% | -$97K |
|
Similar funds
Charles Schwab's Q2 2022 Portfolio in Review
As of Q2 2022, Charles Schwab held 3,742 positions worth $287B, down 14% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2022 filing shows 162 new, 2,018 increased, 1,243 reduced and 206 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $454M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M.
- Charles Schwab added most to Cisco in Q2 2022, an estimated $554M increase.
- Charles Schwab's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $454M.
- Charles Schwab fully exited Cerner Corp in Q2 2022, selling an estimated $140M.
- Charles Schwab's ten largest holdings make up 17% of its $287B portfolio in Q2 2022.
- Charles Schwab opened 162 new positions and closed 206 in Q2 2022.
- Charles Schwab's portfolio value fell 14% quarter-over-quarter to $287B.
Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.